baber/WOPTO huggingface dataset:
Patent AU-2005239836-A1 (AU)
Title: Benzylidene-beta-&bgr;-dicarbonyl compounds as novel UV-absorbers
Inventor: JOHNCOCK WILLIAM
IPC: A61K8/37
Filed: 2005-04-26
Abstract: Use of 1-phenyl-2-arylcarbonyl-ethylene derivatives (I) as UV filters in cosmetic formulations, especially in combination with UV filters of the methoxycinnamate and/or dibenzoylmethane types. Use of 1-phenyl-2-arylcarbonyl-ethylene derivatives of formula (I) as UV filters is cosmetic formulations, especially in combination with UV filters of the methoxycinnamate and/or dibenzoylmethane types. R 1>-R 3> each : hydrogen or 1-8C alkyl or alkoxy; R 4>COR, COOR or CON(R) 2; R : 1-8C alkyl or 3-8C cycloalkyl; R 5>hydrogen or 1-8C alkyl; and R 6>aryl, optionally substituted by 1-3 of 1-8C alkyl or alkoxy, or 3-8C cycloalkyl. With the proviso that R 5> = hydrogen when R 4> = COR. An independent claim is also included for (I) as new compounds when R 1> = para-1-8C alkoxy; R 2>, R 3> and R 5> = hydrogen; R 4> = 1-8C alkoxycarbonyl; R 6> = phenyl or cyclohexyl. [Image] ACTIVITY : Dermatological. MECHANISM OF ACTION : None given.
Patent AU-2005267419-A1 (AU)
Title: Production of valve metal powders with improved physical and electrical properties
Inventor: LANIN LEONID L
IPC: B22F9/20
Filed: 2005-06-21
Abstract: The invention relates to a process that involves (1) feeding (a) a first valve metal powder component containing valve metal particles and (b) reducing component into a reactor having a hot zone; and (2) subjecting the first valve metal powder component and the reducing component to non-static conditions sufficient to simultaneously (i) agglomerate the first valve metal powder component particles, and (ii) reduce oxygen content in the valve metal powder component particles, and thereby form a second valve metal powder component containing oxygen-reduced valve metal particles, in which the reducing component is selected from the group consisting of magnesium reducing components, calcium reducing components, aluminum reducing components, lithium reducing components, barium reducing components, strontium, reducing components, and combinations thereof.
Patent AU-2005289728-A1 (AU)
Title: Methods and compositions for evaluating breast cancer prognosis
Inventor: MARCELPOIL RAPHAEL
IPC: G16B20/00
Filed: 2005-09-22
Abstract: Methods and computer program products for evaluating and optimizing one or more markers for use in establishing a prognosis for a patient suffering from a disease are provided. More particularly, the methods include steps for systematically evaluating a number of features that may be extracted from an image of a body sample, such as a histological slide, that has been exposed to one or more biomarkers so as to establish a prognostic decision rule based on one or more of the extracted features such that the decision rule yields a prognosis that is optimally predictive of actual patient outcome. Thus, the methods and computer program products provided yield optimally predictive prognoses to assist clinicians in developing strategies for effective patient care management.
Patent WO-2007022571-A1 (WO)
Inventor: WATERMAN NORMAN CECIL
IPC: E04H17/14
Filed: 2006-08-22
Abstract: A fencing system and method of fencing installation enable ease of installation using interchangeable components. The system includes at least two posts (305) and at least two perforated rail sections (100) connected to the posts (305). A plurality of palings (310) extend between the at least two perforated rail sections (100). Covering rail sections (200) are assembled adjacent the perforated rail sections (100).
Patent AU-2006235792-A1 (AU)
Title: Hydrophilic polyisocyanate mixtures
IPC: C08G18/34
Filed: 2006-11-01
Abstract: Hydrophilic polyisocyanate mixtures comprise at least one polyacrylate-modified polyisocyanate; optionally, non-polyisocyanates containing aliphatically, cycloaliphatically, aromatically and/or araliphatically attached isocyanate groups; and at least one ionic and/or nonionic emulsifier. Hydrophilic polyisocyanate mixtures comprise at least one polyisocyanate containing at least one structural unit of formula (I); optionally, non-polyisocyanates containing aliphatically, cycloaliphatically, aromatically and/or araliphatically attached isocyanate groups; and at least one ionic and/or nonionic emulsifier. R : H or Me; R 1>optionally heteroatom-containing hydrocarbon radical with up to 22C; R 2>hydrocarbon radical containing at least one isocyanate group and optionally, urethane, allophanate, biuret, uretdione, isocyanurate and/or iminooxadiazinedione units; and n : 1-100. Independent claims are included for: (1) hydrophilicized polyisocyanates based on aromatic, araliphatic, cycloaliphatic, and/or aliphatic polyisocyanates having an isocyanate (NCO) content of 5-25 wt.%, an NCO functionality >=2, a viscosity in solvent-free state of 150-200000 mPa.s at 23[deg]C, containing at least one structural unit of the formula (I) and polyether units of the formula (II) and/or sulfonate and/or phosphate groups; (2) a process for preparing hydrophilic polyisocyanate mixtures by mixing polyisocyanate components mixed with an ionic and/or nonionic emulsifier and/or an emulsifier generated in situ by reacting the polyisocyanate components with hydrophilic, isocyanate-reactive ionic and/or nonionic compounds (the amounts of the starting components are chosen, irrespective of the preparation process, so that the emulsifier is present in 2-60 wt.%, based on the total amount of components); (3) a starting component for polyurethane plastics comprising the hydrophilic polyisocyanate mixtures; (4) a crosslinker component for water-soluble or water- dispersible film-forming binders or film-forming binder components comprising the hydrophilic polyisocyanate mixtures; (5) coating compositions comprising hydrophilic polyisocyanates; and (6) substrates coated with coating compositions. R 3>H or 1-10C alkyl radical; p : 1-1000; and q : 1-3. [Image] [Image].
Patent AU-2006308914-A1 (AU)
Title: Compositions and methods for identifying modulators of TRPV2
Inventor: QIN NING
IPC: A61P39/00
Filed: 2006-10-30
Abstract: It has now been discovered that certain cannabinoids specifically activate TRPV2 channel activity. Based on the discovery, novel compositions and methods for screening, identifying and characterizing compounds that increase or decrease the biological activity of a TRPV2.
Patent WO-2008019425-A1 (WO)
Title: Structure composite et son procédé de préparation
Inventor: SHALLARD GRANT LESLIE
IPC: E04C1/42
Filed: 2007-08-10
Abstract: Structure composite comportant du verre usagé, dans laquelle le verre usagé peut être écrasé, broyé et/ou réduit en poudre. La structure composite a, de préférence, la forme d'une planche de construction. L'invention concerne un procédé conçu pour utiliser le verre usagé, comprenant l'étape de formation d'une structure composite à partir du verre usagé. Le procédé peut inclure les étapes qui consistent à traiter le verre usagé par écrasement, broyage et/ou réduction en poudre; combiner le verre traité avec un matériau de liaison pour former une pâte; et séparer le matériau solide de la pâte pour former la structure composite.
Patent AU-2007304465-A1 (AU)
Title: Polyolefin composition with increased resistance to CIO2-containing water
Inventor: BACKMAN MATS
IPC: C08K5/372
Filed: 2007-09-26
Abstract: The present invention relates to a polyolefin composition comprising a polyolefin base resin and an antioxidant, characterized in that said polyolefin composition has a lifetime of at least 200 h in a test measuring the resistance against ClO 2 -containing water at 90 °C and at a concentration of ClO 2  of 4 ppm wherein the equipment used is according to ASTM F2263-03.  The present invention further relates to a pipe comprising the polyolefin composition according to the invention, to the use of the polyolefin composition for the production of a pipe, and to the use of a particularly selected antioxidant for increasing the resistance of a polyolefin composition against degradation caused by contact with ClO 2 -containing water.
Patent AU-2007331903-A1 (AU)
Title: Process for the biological generation of methane
Inventor: SALVETZKI RALF
IPC: C12P5/02
Filed: 2007-12-11
Abstract: A process is specified for the biological generation of methane (CH4), which process is firstly environmentally friendly and inexpensive, and secondly avoids the use of fossil deposits. The process is divided into two steps, wherein first hydrogen (H2) and oxygen (O2) are generated from carbon dioxide (CO2) and water (H2O) by algae with the action of light. In the second step, methane (CH4) is isolated by methanogenesis bacteria from the hydrogen (H2) which is generated and from carbon dioxide (CO2). To increase the yield of the process, interfering intracellular oxygen (O2) can be bound in the algae and/or in the methanogenesis bacteria.
Patent WO-2008124875-A1 (WO)
Title: Avertisseurs de fuite de gaz
Inventor: BARBER KEVIN ROBERT
IPC: G08B21/16
Filed: 2008-04-14
Abstract: La présente invention concerne un avertisseur de fuite de gaz apte à être connecté à une source d'énergie électrique comportant une unité de détection pour le type de gaz à détecter, un moyen d'alimentation pour faire fonctionner une résistance chauffante dans le capteur et le circuit restant. Lorsque la sortie du capteur indique la présence d'un gaz à détecter, ledit moyen entraîne l'activation d'un dispositif avertisseur. Le dispositif peut détecter différents gaz sélectionnés et peut être utilisé dans des zones fermées d'immeubles ou des véhicules automobiles.
Patent AU-2008333606-A1 (AU)
Title: Screen system with tube-shaped screen and method for operating a screen system with tube-shaped screen
Inventor: KISING JURGEN
IPC: B07B1/42
Filed: 2008-11-25
Abstract: The system (3) has a tube or screen frame (31), which is subjected to ultrasound stimulation by an ultrasound converter (13) and a feed pipe sound converter (34). The converter (34) is designed such that amplitude of the stimulation comprises components in a vertical direction to a middle axis of a tube-like screen, and components in a parallel direction to the middle axis of the tube-like screen. The amplitude is transferred to a tube or to the screen frame. The feed pipe sound converter comprises a curved region with a curvature angle of maximum of 90 degrees. An independent claim is also included for a method for operating a screening system.
Patent WO-2010025505-A1 (WO)
Title: Analgésie par administration transmuqueuse
Inventor: KELLY ALEXANDER JAMES
IPC: A61P23/00
Filed: 2009-09-02
Abstract: L'invention concerne une composition comprenant une solution d'au moins un anesthésique volatil, la composition étant administrée par voie transmuqueuse pour le traitement d'une douleur, et un procédé de traitement d'une douleur comprenant l'administration transmuqueuse de la composition.
Patent WO-2010025516-A1 (WO)
Inventor: MURDOCH GRAHAM ALEXANDER MUNRO
IPC: H04B5/00
Filed: 2009-09-04
Abstract: L’invention se rapporte au domaine de la transmission de signaux RF. Selon un aspect, l’invention concerne l’utilisation de modules d’impédance afin d’améliorer la transmission de signaux à des taux de données relativement élevés comme, par exemple, la transmission de signaux entre un premier dispositif, tel qu’une antenne, et un second dispositif tel qu’un dispositif associé comme un interrogateur, un pilote et/ou un lecteur.
Patent WO-2010031126-A1 (WO)
Title: Humidification de gaz respiratoires
Inventor: VIRR ALEXANDER
IPC: A61M16/16
Filed: 2009-09-17
Abstract: L'invention concerne un humidificateur (14) permettant d'humidifier un flux de gaz respirable destiné à être administré à un patient qui inclut une chambre (16) configurée pour recevoir le flux de gaz respirable ; un tube (20) configuré pour contenir une alimentation d'eau, le tube étant configuré pour être inséré dans la chambre ; un couvercle (18) disposé sur la chambre et mobile entre une position ouverte et une position fermée ; et un joint d'étanchéité (19) fourni sur le couvercle, le joint d'étanchéité étant configuré pour fermer hermétiquement le chambre de sorte que le flux de gaz respirable mette sous pression la chambre. L'humidificateur peut se brancher à un générateur de flux (12) configuré pour générer le flux de gaz respirable. Un tube permettant d'administrer le flux humidifié peut être branché à l'humidificateur. Le tube peut être un tube chauffé ou non chauffé. Un appareil respiratoire permettant d'administrer un flux de gaz respirable à un patient peut inclure l'humidificateur et le générateur de flux et/ou le tube. Un procédé d'humidification d'un flux de gaz respirable comprend la fermeture étanche d'une chambre contenant une alimentation d'eau et la mise sous pression de la chambre en dirigeant le flux de gaz respirable dans la chambre.
Patent AU-2009200876-A1 (AU)
Title: Penetrable cap
Inventor: KENNEDY MARK R
IPC: B01L99/00
Filed: 2009-03-05
Abstract: The invention relates to a closed system comprising a cap fixed to a vessel in sealing engagement, thereby preventing a fluid contained in the system from escaping into the environment, the cap having affixed first and second foil seals and the second seal being axially aligned with and positioned below the first seal.
Patent AU-2009238279-A1 (AU)
Title: Minimizing bandwidth costs for online games
Inventor: MIYAKI KEN
IPC: H04L29/06
Filed: 2009-11-13
Abstract: A method for reducing bandwidth cost for a participant in an online game comprises: querying the game participant to determine a network service charge model; selecting a role for the game participant, from a set of available roles, based on the determined network service charge model and a position of the participant in a network topology, the selected role being one of the available roles so that the participant's bandwidth cost is reduced with respect to at least one other of the set of available roles; and positioning the game participant into the selected role within the network topology of the online game.
Patent AU-2009336800-A1 (AU)
Title: Cancer treatment
Inventor: KATHRIN SCHWAGER
IPC: A61P35/00
Filed: 2009-12-23
Abstract: The invention relates to the treatment of cancer, e.g. kidney cancer, using chemotherapeutic agents and immunocytokines, in particular immunocytokines which bind to the Extra Domain-A (ED-A) isoform of fibronectin.
Patent AU-2009342159-A1 (AU)
Title: Caloric burn undergarment
Inventor: DENISE PERRON
IPC: A41B9/00
Filed: 2009-12-30
Abstract: The present application relates generally to the field of underwear and undergarments. More particularly, the present application relates to a novel undergarment that induces caloric burn while the person wearing it goes about his or her daily activities. An objective for the underwear is to increase exercise of body muscles used in daily living. In one embodiment, the present application provides a novel undergarment and/or shaper with carefully positioned non-stretch bands, or the equivalent thereof, that are relatively more resistant (i.e., less stretchy or elastic) than the fabric that is used to construct the remainder of the undergarment. These bands have a direct effect on muscles that would normally be activated during regular activity and cause them to be exercised to a further degree, but in a gentle manner. The effect, which in many cases is slightly perceptible, is felt while the wearer goes about his or her daily routine.
Patent AU-2009355272-A1 (AU)
Title: Tray for housing splices between optical fibers
Inventor: ABBIATI FABIO
IPC: G02B6/44
Filed: 2009-11-12
Abstract: It is disclosed a tray (T) for housing optical fiber splices. The tray (T) comprises a splice holding area (A1) in turn comprising a number of splice holders. The number of splice holders is arranged according to a two-dimensional arrangement comprising at least a first column (C1) and a second column (C2). The first column (C1) comprises at least one first splice holder (SH11-SH81) and at least one first fiber passageway (FP11, FP21) suitable for housing a length of at least one first optical fiber (F3-F6, F11-F14) so that it bypasses the first column (C1). The second column (C2) comprises at least one second splice holder (SH12-SH82) and at least one second fiber passageway (FP12, F22) suitable for housing a length of at least one second optical fiber (F1-F2, F7-F10, F15-F16) so that it bypasses the second column (C2).
Patent WO-2010105293-A1 (WO)
Title: Ensemble lame niveleuse
Inventor: GUIMARAES MIGUEL
IPC: E02F9/28
Filed: 2010-03-16
Abstract: L'invention concerne un ensemble lame niveleuse comprenant une lame niveleuse dotée d'un corps de niveleuse et d'au moins une saillie s'étendant à l'extérieur du corps de niveleuse pour former au moins une ouverture pour pic ; au moins un pic placé dans l'ouverture ou les ouvertures pour pic ; et au moins un dispositif de blocage fixé au corps de lame niveleuse, ledit dispositif de blocage venant en butée avec le ou les pics pour empêcher le retrait du ou des pics depuis l'ouverture ou les ouvertures pour pic.
Patent AU-2010210593-A1 (AU)
Title: Nanoscale platinum compounds and methods of use thereof
Inventor: SHILADITYA SENGUPTA
IPC: A61K33/243
Filed: 2010-02-04
Abstract: The invention is directed to biocompatible conjugated polymer nanoparticles including a copolymer backbone, a plurality of sidechains covalently linked to said backbone, and a plurality of platinum compounds dissociably linked to said backbone. The invention is also directed to dicarbonyl-lipid compounds wherein a platinum compound is dissociably linked to the dicarbonyl compound. The invention is also directed to methods of treating cancer or metastasis. The methods includes selecting a subject in need of treatment for cancer or metastasis and administering to the subject an effective amount of any of the nanoparticles, compounds, or compositions of the invention.
Patent AU-2010212715-A1 (AU)
Title: Apparatus for pouring a liquid into a glass, in particular wine
Inventor: PAUL RIVIER
IPC: B67D1/10
Filed: 2010-02-10
Abstract: The invention relates to an apparatus (1) for pouring into a glass (2) in order to reduce the risks of spoiling the wine (3) poured by said apparatus. Vacuum tapping means (10) are sealingly connected to the upper portion (4A) of the vessel (4) and maintain a pressure therein which is between a first predetermined value P1 lower than the atmospheric pressure and a predetermined value P2 lower than P1, and liquid tapping means (20) are sealingly connected to the lower portion (4B) of the vessel and pump liquid from said lower portion up to an area for pouring into a glass. The vacuum tapping means includes a vacuum source (11) for lowering the pressure in the upper portion (4A) of the vessel (4) to P1 and vacuum partial-compensation means (14) adapted for feeding a gaseous fluid into the upper portion of the vessel when the pressure in said upper portion is lower than P2.
Patent AU-2010222818-A1 (AU)
Title: Mirac proteins
Inventor: SHORT JAY M
IPC: A61K38/095
Filed: 2010-03-09
Abstract: This disclosure relates to a method of generating conditionally active biologic proteins from wild type proteins, in particular therapeutic proteins, which are reversibly or irreversibly inactivated at the wild type normal physiological conditions. For example, evolved proteins are virtually inactive at body temperature, but are active at lower temperatures.
Patent AU-2010245594-A1 (AU)
Title: Communication device, communication method, and communication system
Inventor: RYOTA KIMURA
IPC: H04J99/00
Filed: 2010-04-19
Abstract: Frames in variable-length frame formats addressed to a plurality of users are multiplexed and suitably transmitted. Data frames with different lengths are multiplexed at the same time through space division multiple access. However, the frames to be multiplexed are eventually adjusted to the same length and then transmitted, so that, when the multiplexed data frames are received by each communication station (STA1 to STA3) from an access point (STA0) in Fig. 4, or when the data transmitted from each communication station (STA1 to STA3) at the same time is received by the access point (STA0) in Fig. 5, operation instability in AGC (Auto Gain Control) can be eliminated.
Patent AU-2010251966-A1 (AU)
Title: Combination of a TNF-alpha antagonist and a VEGF antagonist for use in the treatment or prevention of diseases of the eye.
Inventor: PETER ADAMSON
IPC: A61K39/395
Filed: 2010-05-26
Abstract: The invention relates to combinations of TNFα antagonists with VEGF antagonists for use in treating diseases of the eye, and provides antigen-binding proteins which bind to TNFα or a TNFα receptor and/or VEGF or a VEGF receptor.
Patent AU-2010253840-A1 (AU)
Title: Apparatus and method for the removal and containment of human waste excretion
Inventor: BOURKE EDWARD
IPC: A61M35/00
Filed: 2010-05-27
Abstract: The present invention relates to an apparatus for the removal and containment of human waste products from the effected area of incontinent patients. The apparatus and process encapsulates the areas of the body where urine and fecal matter are excreted. In particular, the present invention is directed to an apparatus for the containment and removal of human waste products, comprising: a receptacle; a vacuum connection to apply force for attaching the receptacle to the patient; and a vacuum dispersion membrane to provide mechanical support to the skin so as to minimize tensile force applied to the skin.
Patent AU-2010254119-A1 (AU)
Title: Thin films for photovoltaic cells
Inventor: RAKESH AGRAWAL
IPC: B32B37/00
Filed: 2010-05-26
Abstract: In one aspect, a method for forming CIGSSe-based thin films includes depositing at least two layers of particles on a substrate. At least one layer includes a CIGSSe particle having a chemical composition denoted by Cu(InI -xGax)(S1 - ySey)2 where 0≤x≤1 and 0≤y≤1. The particle layers are annealed individually or in combination to form a CIGSSe thin film having a composition profile along the depth of the film. In addition, one or more of the particle layers may be also deposited on a pre-existing absorber and annealed to form a film having a composition profile along the depth of the film. After depositing thin film precursor layers containing CIGSSe nanoparticles (and/or any other particles) on a suitable substrate in accordance with a desired concentration profile, a subsequent treatment under an Se and/or S containing atmosphere at elevated temperature may be used to convert the precursor layers into a CIGSSe absorber film. In a further aspect, a method for forming multinary metal chalcogenide semiconductor layers directly on a substrate from a solution of precursors, includes depositing a plurality of metal chalcogenide particles onto a substrate to form a precursor film. A species containing a metal, chalcogen, or combination thereof is dissolved in a solution containing one or more solvents to form a liquid chalcogen medium. The precursor film is contacted with the liquid chalcogen medium at a temperature of at least 50 C to form a multinary metal chalcogenide thin film.
Patent AU-2010273732-A1 (AU)
Title: 5-HT3 receptor modulators, methods of making, and use thereof
Inventor: GUZZO PETER R
IPC: A61P25/00
Filed: 2010-06-30
Abstract: Novel 5-HT receptor modulators are disclosed. These compounds are used in the treatment of various disorders, including chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, and irritable bowel syndrome. Methods of making these compounds are also described in the present invention.
Patent AU-2010299920-A1 (AU)
Title: Method and reactor for treating bulk material containing carbon
Inventor: JAEGER HUBERT
IPC: B09B3/00
Filed: 2010-09-23
Abstract: The invention relates to a method for treating bulk material which contains carbon and impurities. According to the invention, bulk material is directly heated inductively inside a reactor.